{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:11:58Z","timestamp":1794345118173,"version":"4.9.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":4114,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1111\/j.1523-1755.2004.00867.x","type":"journal-article","created":{"date-parts":[[2004,8,11]],"date-time":"2004-08-11T10:55:11Z","timestamp":1092221711000},"page":"1159-1166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":221,"title":["Tamm-Horsfall protein is a critical renal defense factor protecting against calcium oxalate crystal formation"],"prefix":"10.1016","volume":"66","author":[{"given":"Lan","family":"Mo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Hua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Hasty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Ru","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0010","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(01)05782-8","article-title":"Recurrent renal stone disease-advances in pathogenesis and clinical management","volume":"358","author":"Bihl","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0015","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S1570-0232(02)00557-3","article-title":"Urinary analysis of nephrolithiasis markers","volume":"781","author":"Barbas","year":"2002","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0020","first-page":"S45","article-title":"Epidemiology of nephrolithiasis","volume":"13","author":"Ramello","year":"2000","journal-title":"J Nephrol"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0025","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000030214","article-title":"Urinary kidney stone inhibitors. What is the news?","volume":"60","author":"Dussol","year":"1998","journal-title":"Urol Int"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0030","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00042307-200207000-00002","article-title":"Crystal-cell interaction in the pathogenesis of kidney stone disease","volume":"12","author":"Asselman","year":"2002","journal-title":"Curr Opin Urol"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0035","first-page":"305","article-title":"Nephrolithiasis: A consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals","volume":"4","author":"Khan","year":"2000","journal-title":"Mol Urol"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000283025","article-title":"Interactions between stone-forming calcific crystals and macromolecules","volume":"59","author":"Khan","year":"1997","journal-title":"Urol Int"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0045","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/j.1523-1755.1998.00839.x","article-title":"Control of calcium oxalate crystal structure and cell adherence by urinary macromolecules","volume":"53","author":"Wesson","year":"1998","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0050","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0945-053X(00)00108-6","article-title":"Osteopontin: A versatile regulator of inflammation and biomineralization","volume":"19","author":"Giachelli","year":"2000","journal-title":"Matrix Biol"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0055","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1084\/jem.20020911","article-title":"Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: Evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo","volume":"196","author":"Speer","year":"2002","journal-title":"J Exp Med"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0060","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1523-1755.1998.00745.x","article-title":"Quantitative studies of human urinary excretion of uropontin","volume":"53","author":"Min","year":"1998","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/qjmed\/95.1.3","article-title":"Osteopontin\u2014A molecule for all seasons","volume":"95","author":"Mazzali","year":"2002","journal-title":"Q J Med"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0070","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1046\/j.1523-1755.2001.00032.x","article-title":"Expression, roles, receptors, and regulation of osteopontin in the kidney","volume":"60","author":"Xie","year":"2001","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0075","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0022-5347(05)64621-6","article-title":"Expression of osteopontin in rat kidneys: induction during ethylene glycol induced calcium oxalate nephrolithiasis","volume":"168","author":"Khan","year":"2002","journal-title":"J Urol"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0080","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1172\/JCI2131","article-title":"Altered wound healing in mice lacking a functional osteopontin gene (spp1)","volume":"101","author":"Liaw","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0085","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/01.ASN.0000040593.93815.9D","article-title":"Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules","volume":"14","author":"Wesson","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0090","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/ki.1990.128","article-title":"Tamm-Horsfall protein\u2014Uromodulin (1950\u20131990)","volume":"37","author":"Kumar","year":"1990","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0095","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0272-6386(03)00829-1","article-title":"Tamm-Horsfall glycoprotein: Biology and clinical relevance","volume":"42","author":"SERAFINI-CESSI","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0100","doi-asserted-by":"crossref","first-page":"20784","DOI":"10.1016\/S0021-9258(17)45284-7","article-title":"Uromodulin (Tamm-Horsfall glycoprotein\/uromucoid) is a phosphatidylinositol-linked membrane protein","volume":"265","author":"Rindler","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0105","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1006\/bbrc.2000.4090","article-title":"Mechanism of release of urinary Tamm-Horsfall glycoprotein from the kidney GPI-anchored counterpart","volume":"280","author":"Cavallone","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0110","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1006\/bbrc.2001.6112","article-title":"Analysis of the C-terminal structure of urinary Tamm-Horsfall protein reveals that the release of the glycosyl phosphatidylinositol-anchored counterpart from the kidney occurs by phenylalanine-specific proteolysis","volume":"289","author":"Fukuoka","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0115","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF00294343","article-title":"Tamm-Horsfall glycoprotein\u2014Inhibitor or promoter of calcium oxalate monohydrate crystallization processes?","volume":"20","author":"Hess","year":"1992","journal-title":"Urol Res"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0120","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1681\/ASN.V55s46","article-title":"Urinary calcium oxalate crystal growth inhibitors","volume":"5","author":"Worcester","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0125","doi-asserted-by":"crossref","first-page":"F795","DOI":"10.1152\/ajprenal.00357.2003","article-title":"Ablation of the Tamm-Horsfall protein gene increases the susceptibility of mice to bladder colonization by type 1 fimbriated Escherichia coli","volume":"286","author":"Mo","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0130","first-page":"115","article-title":"Etiology of calcium oxalate nephrolithiasis in rats. II. The role of the papilla in stone formation","volume":"9","author":"DE BRUIJN","year":"1995","journal-title":"Scanning Microsc"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/glycob\/9.1.21","article-title":"Glycosylation sites and site-specific glycosylation in human Tamm-Horsfall glycoprotein","volume":"9","author":"VAN ROOIJEN","year":"1999","journal-title":"Glycobiology"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0140","doi-asserted-by":"crossref","first-page":"18696","DOI":"10.1016\/S0021-9258(17)44808-3","article-title":"Physiological properties and differential glycosylation of phosphorylated and nonphosphorylated forms of osteopontin secreted by normal rat kidney cells","volume":"265","author":"Singh","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0145","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0022-5347(17)39793-8","article-title":"Cell injury associated calcium oxalate crystalluria","volume":"144","author":"Hackett","year":"1990","journal-title":"J Urol"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0150","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/jmg.39.12.882","article-title":"Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy","volume":"39","author":"Hart","year":"2002","journal-title":"J Med Genet"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0155","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1093\/hmg\/ddg353","article-title":"Allelism of MCKD, FJHN and GCKD caused by impairment of uromodulin export dynamics","volume":"12","author":"Rampoldi","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0160","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1097\/01.ASN.0000092147.83480.B5","article-title":"A cluster of mutations in the UMOD gene causes familial juvenile hyperuricemic nephropathy with abnormal expression of uromodulin","volume":"14","author":"Dahan","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0165","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1046\/j.1523-1755.2003.00081.x","article-title":"Clinical characterization of a family with a mutation in the uromodulin (Tamm-Horsfall glycoprotein) gene","volume":"64","author":"Bleyer","year":"2003","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0170","first-page":"261","article-title":"Dietary calcium, dietary protein, and kidney stone formation","volume":"23","author":"Curhan","year":"1997","journal-title":"Miner Electrolyte Metab"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00001432-199502000-00001","article-title":"Editorial Comment: Sexually transmitted diseases and urinary tract infections","volume":"8","author":"Ronald","year":"1995","journal-title":"Curr Opin Infect Dis"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0180","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0009-9120(96)00136-1","article-title":"Decreased Tamm-Horsfall protein in lithiasic patients","volume":"30","author":"Romero","year":"1997","journal-title":"Clin Biochem"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0185","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/ndt\/15.10.1580","article-title":"Determinants of urinary excretion of Tamm-Horsfall protein in non-selected kidney stone formers and healthy subjects","volume":"15","author":"Glauser","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0190","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1464-410X.1997.00366.x","article-title":"Effects of Tamm-Horsfall protein with normal and reduced sialic acid content upon the crystallization of calcium phosphate and calcium oxalate in human urine","volume":"80","author":"Hallson","year":"1997","journal-title":"Br J Urol"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0195","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1007\/BF01946918","article-title":"A simple diagnostic method for the differentiation of Tamm-Horsfall glycoproteins from healthy probands and those from recurrent calcium oxalate renal stone formers","volume":"51","author":"Schnierle","year":"1995","journal-title":"Experientia"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0200","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/clinchem\/33.7.1264a","article-title":"Pronounced decrease of Tamm-Horsfall proteinuria in diabetics","volume":"33","author":"Bernard","year":"1987","journal-title":"Clin Chem"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0205","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2362.1988.tb01252.x","article-title":"Tamm Horsfall glycoprotein in diabetes mellitus: abnormal chemical composition and colloid stability","volume":"18","author":"Rambausek","year":"1988","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/j.1523-1755.2004.00867.x_bb0210","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1007\/BF00301528","article-title":"Prophylaxis of infection-induced kidney stone formation","volume":"18","author":"Hess","year":"1990","journal-title":"Urol Res"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815501683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815501683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:43:32Z","timestamp":1758761012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815501683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0085253815501683"],"URL":"https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00867.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tamm-Horsfall protein is a critical renal defense factor protecting against calcium oxalate crystal formation","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00867.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}